ArticleJCO precision oncology2019

Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced Cancers.

Scott Kopetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.